Vical inks $4M contract to manufacture HIV vaccine; Buffalo, NY, cancer institute to develop lung cancer vax with Cuban partner;

> San Diego-based Vical ($VICL) signed a $4 million contract with the IPPOX Foundation to supply plasmid DNA for HIV vaccine clinical trials. It is funded by a grant from the Bill & Melinda Gates Foundation. Release

> The Roswell Park Cancer Institute in Buffalo, New York, signed an agreement with Cuba's Center for Molecular Immunology to develop a lung cancer vaccine. News

> A large study published by JAMA shows no link between the MMR vaccine and autism. More (sub. req.)

> Researchers in Singapore and China have developed nanoparticle-coated bacteria that can potentially be used to deliver DNA cancer vaccines. FierceDrugDelivery story | More

And Finally… U.S. Surgeon General Vivek Murthy explains vaccination to Elmo in a video produced by The Daily Dot. Video

Suggested Articles

With its phase 3 trial moving right along, Moderna is expecting efficacy data in November—likely after Pfizer and BioNTech, but before everyone else.

BioNTech expects a quick turnaround once the transaction closes and plans to produce up to 250 million doses of BNT162b2 in the first half of 2021.

Participation in clinical trials among Black people is low, FDA statistics show, even as drugmakers prioritize including them in COVID-19 shot trials.